NCT02882945View on ClinicalTrials.gov

Gene Polymorphism Associated With Macroangiopathy in Type 2 Diabetes Patients

CompletedOBSERVATIONAL
Enrollment

470

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

September 30, 2015

Conditions
Diabetic Angiopathies
Interventions
OTHER

Group A

150 healthy blood donors without a family history of diabetes mellitus were enrolled in the study.

OTHER

Group B

200 cases of type 2 DM without complications were enrolled in the study.

OTHER

Group C

120 cases of type 2 DM with macroangiopathy complication were enrolled in the study.. Among the group C subjects, 65 individuals had CHD; 55 patients had cerebrovascular disease (CVD); and 30 subjects had a combination of peripheral vascular diseases (PVD) and CHD.

All Listed Sponsors
lead

First Affiliated Hospital of Harbin Medical University

OTHER

NCT02882945 - Gene Polymorphism Associated With Macroangiopathy in Type 2 Diabetes Patients | Biotech Hunter | Biotech Hunter